Skip to content

Israel-Based Healthcare Investor aMoon Expands to Boston, Is Raising Growth Fund – The Wall Street Journal

Israel-Based Healthcare Investor aMoon Expands to Boston, Is Raising Growth Fund – The Wall Street Journal

Yair Schindel, co-founder and managing partner of aMoon Fund. Photo: aMoonAMoon Fund, an Israel-based venture investor that has backed high-profile U.S. healthcare companies such as Ultima Genomics Inc., has opened a Boston office and raised $340 million toward its second growth fund. ​Founded in 2017, aMoon is a global investment firm that funds private and publicly traded companies. Its portfolio includes U.S. companies such as Ultima, which has secured more than $600 million in venture funding to develop new DNA-sequencing technology, and Omada Health Inc., a provider of virtual healthcare that closed a $192 million late-stage venture round last year. Copyright… 

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *